Memory formation in old age requires GSK-3β
Riki Koike1, Yuta Takaichi2, Yoshiyuki Soeda1
1Laboratory for Alzheimer's Disease, Department of Life Science, Faculty of Science, Gakushuin University, 1-5-1 Mejiro, Toshima-ku, Tokyo 171-8588, Japan.
Abstract:
Glycogen synthase kinase 3β (GSK-3β) is a therapeutic target for various age-related neurodegenerative diseases. It is linked to the two main pathological features of Alzheimer's disease (AD), tau and amyloid β (Aβ); GSK-3β is a major candidate to pathologically hyperphosphorylate tau and modulate Aβ production. However, inhibition of GSK-3β in clinical studies in humans has been found to not significantly improve cognitive function of AD patients, prompting us to study the physiological role of GSK-3β in old mice. Using a contextual fear-conditioning paradigm, we now report that old gsk-3β+/- mice are deficient in both short-term and long-term memory formation, suggesting that GSK-3β is required for memory formation at old age. Biochemical and immunohistochemical analyses showed that the number of synapses does not differ between gsk-3β+/- and age-matched wild-type (wt) littermate mice. Based on these observations, we propose that, GSK-3β may contribute to help maintain brain function during aging. Our results may explain the poor efficacy of GSK-3β inhibitors in preserving memory capacity in AD patients.
Insights
Glycogen synthase kinase 3β (GSK-3β) is crucial for memory in aging mice. Reduced GSK-3β impairs both short-term and long-term memory, suggesting a role in maintaining brain function during aging.
Area of Science:
- Neuroscience
- Molecular Biology
- Aging Research
Background:
- Glycogen synthase kinase 3β (GSK-3β) is implicated in neurodegenerative diseases like Alzheimer's disease (AD).
- GSK-3β is linked to tau hyperphosphorylation and amyloid-beta (Aβ) production, key pathological hallmarks of AD.
- Clinical trials inhibiting GSK-3β in AD patients showed limited cognitive benefits.
Purpose of the Study:
- To investigate the physiological role of GSK-3β in memory formation during old age.
- To understand why GSK-3β inhibition failed to improve cognitive function in AD patients.
Main Methods:
- Utilized a contextual fear-conditioning paradigm in old mice.
- Performed biochemical and immunohistochemical analyses on gsk-3β+/- and wild-type (wt) littermate mice.
Main Results:
- Old gsk-3β+/- mice exhibited deficits in both short-term and long-term memory formation.
- Synapse numbers were comparable between gsk-3β+/- and wt mice, indicating GSK-3β's role is not dependent on synapse count.
Conclusions:
- GSK-3β is essential for memory formation in aged mice.
- GSK-3β may play a vital role in maintaining brain function throughout the aging process.
- These findings may explain the limited efficacy of GSK-3β inhibitors in AD patients.
Related Concept Videos
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Long-term Potentiation


